Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-312024-01-01falsefalseGrowing and distributing plants and shrubs6569truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 00748302 2024-01-01 2024-12-31 00748302 2023-01-01 2023-12-31 00748302 2024-12-31 00748302 2023-12-31 00748302 c:Director1 2024-01-01 2024-12-31 00748302 d:Buildings 2024-01-01 2024-12-31 00748302 d:Buildings 2024-12-31 00748302 d:Buildings 2023-12-31 00748302 d:Buildings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00748302 d:Buildings d:LongLeaseholdAssets 2024-01-01 2024-12-31 00748302 d:Buildings d:LongLeaseholdAssets 2024-12-31 00748302 d:Buildings d:LongLeaseholdAssets 2023-12-31 00748302 d:PlantMachinery 2024-01-01 2024-12-31 00748302 d:PlantMachinery 2024-12-31 00748302 d:PlantMachinery 2023-12-31 00748302 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00748302 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00748302 d:CurrentFinancialInstruments 2024-12-31 00748302 d:CurrentFinancialInstruments 2023-12-31 00748302 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 00748302 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 00748302 d:ShareCapital 2024-12-31 00748302 d:ShareCapital 2023-12-31 00748302 d:CapitalRedemptionReserve 2024-12-31 00748302 d:CapitalRedemptionReserve 2023-12-31 00748302 d:RetainedEarningsAccumulatedLosses 2024-12-31 00748302 d:RetainedEarningsAccumulatedLosses 2023-12-31 00748302 c:FRS102 2024-01-01 2024-12-31 00748302 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 00748302 c:FullAccounts 2024-01-01 2024-12-31 00748302 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 00748302 d:WithinOneYear 2024-12-31 00748302 d:WithinOneYear 2023-12-31 00748302 d:BetweenOneFiveYears 2024-12-31 00748302 d:BetweenOneFiveYears 2023-12-31 00748302 d:MoreThanFiveYears 2024-12-31 00748302 d:MoreThanFiveYears 2023-12-31 00748302 2 2024-01-01 2024-12-31 00748302 6 2024-01-01 2024-12-31 00748302 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 00748302










DARBY NURSERY STOCK LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
DARBY NURSERY STOCK LIMITED
REGISTERED NUMBER: 00748302

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
677,697
687,931

Investments
 5 
60
60

  
677,757
687,991

Current assets
  

Stocks
  
2,005,422
1,656,225

Debtors: amounts falling due within one year
 6 
148,858
118,766

Cash at bank and in hand
  
948,134
1,384,280

  
3,102,414
3,159,271

Creditors: amounts falling due within one year
 7 
(414,779)
(437,852)

Net current assets
  
 
 
2,687,635
 
 
2,721,419

Total assets less current liabilities
  
3,365,392
3,409,410

Provisions for liabilities
  

Deferred tax
  
(41,758)
(56,287)

  
 
 
(41,758)
 
 
(56,287)

Net assets
  
3,323,634
3,353,123

Page 1

 
DARBY NURSERY STOCK LIMITED
REGISTERED NUMBER: 00748302
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024

2024
2023
£
£

Capital and reserves
  

Called up share capital 
  
1,000
1,000

Capital redemption reserve
  
5,000
5,000

Profit and loss account
  
3,317,634
3,347,123

  
3,323,634
3,353,123


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
A R Darby
Director

Date: 3 September 2025

The notes on pages 8 to 14 form part of these financial statements.

Page 2

 
DARBY NURSERY STOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Darby Nursery Stock Limited is a private company limited by shares and incorporated in England and Wales, registration number 00748302. The registered office is Old Feltwell Road, Methwold, Thetford, Norfolk, IP26 4PW.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are presented in sterling which is the functional currency of the Company and rounded to the nearest £.
The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

 
2.2

Going concern

The director has considered the Company’s position at the time of signing the financial statements. In assessing the appropriateness of the going concern basis, the director has considered the  Company’s current financial strength and trading performance. 
Based on this, the director has concluded that he has a reasonable expectation that the Company will have adequate resources to continue in operational existence for the foreseeable future and at least twelve months from the date of signing these financial statements. The director therefore continues to adopt the going concern basis of accounting in preparing these financial statements.

 
2.3

Turnover

Turnover comprises the sale of goods excluding sales taxes and rebates. It is recognised at the point of dispatch of goods to customers and is stated net of returns.
Turnover relates to the sale of ornamental shrubs, climbing plants, herbaceous perennials and trees.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
DARBY NURSERY STOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is provided on the following basis:

Freehold property
-
4, 5, 10, 15 or 25% straight line
Property improvements
-
5, 10 or 15% straight line
Plant and machinery
-
20 or 25% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Income and Retained Earnings.

 
2.5

Valuation of investments

Investments in associates are measured at cost less accumulated impairment.

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Statement of Income and Retained Earnings.

 
2.7

Debtors

Short term debtors are measured at transaction price, less any impairment. 

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. 

 
2.9

Financial instruments


The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

 
2.10

Creditors

Short term creditors are measured at the transaction price.

Page 4

 
DARBY NURSERY STOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.11

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. 
Grants of a revenue nature are recognised in the Statement of Income and Retained Earnings in the same period as the related expenditure.

 
2.12

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of Income and Retained Earnings.

 
2.13

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

 
2.14

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to the Statement of Income and Retained Earnings on a straight-line basis over the lease term.

 
2.15

Pensions

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.
The contributions are recognised as an expense in the Statement of Income and Retained Earnings when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

Page 5

 
DARBY NURSERY STOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.16

Interest income

Interest income is recognised in the Statement of Income and Retained Earnings using the effective interest method.

  
2.17

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
Increases in provisions are generally charged as an expense to the Statement of Income and Retained Earnings.

 
2.18

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
 
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

 
2.19

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

Page 6

 
DARBY NURSERY STOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 65 (2023 - 69).


4.


Tangible fixed assets





Freehold property
Property improve-ments
Plant and machinery
Total

£
£
£
£



Cost or valuation


At 1 January 2024
1,051,757
1,772,609
1,354,866
4,179,232


Additions
-
-
111,957
111,957



At 31 December 2024

1,051,757
1,772,609
1,466,823
4,291,189



Depreciation


At 1 January 2024
603,336
1,754,310
1,133,655
3,491,301


Charge for the year on owned assets
10,399
10,979
100,813
122,191



At 31 December 2024

613,735
1,765,289
1,234,468
3,613,492



Net book value



At 31 December 2024
438,022
7,320
232,355
677,697



At 31 December 2023
448,421
18,299
221,211
687,931

Page 7

 
DARBY NURSERY STOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Fixed asset investments





Investments in associates

£



Cost or valuation


At 1 January 2024
60



At 31 December 2024
60





6.


Debtors

2024
2023
£
£


Trade debtors
32,646
61,756

Other debtors
100,101
44,520

Prepayments and accrued income
16,111
12,490

148,858
118,766



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
166,187
140,711

Corporation tax
19,001
91,399

Other taxation and social security
44,947
40,548

Other creditors
19,901
20,031

Accruals and deferred income
164,743
145,163

414,779
437,852


Page 8

 
DARBY NURSERY STOCK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

8.


Commitments under operating leases

At 31 December 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
58,977
58,977

Later than 1 year and not later than 5 years
199,964
210,786

Later than 5 years
192,620
-

451,561
269,763

 
Page 9